Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 4
1(50.0%)
N/A
1(50.0%)
2Total
Phase 4(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06633159Recruiting

MitraClip in Patients With Heart Failure

Role: lead

NCT04728217Phase 4Completed

Health Related Quality of Life of Youth and Young Adults With Haemophilia A

Role: lead

NCT04863274Completed

Influence of Additional Physician's Consultations and Short Message Service (SMS) Reminders to Patient Compliance

Role: lead

NCT03927196Not ApplicableCompleted

Primary Prevention Program

Role: collaborator

NCT03119454Completed

"Corticoid-16" in Long Term When Administered Systemically in Patients in Routine Medical Practice

Role: collaborator

All 5 trials loaded